Race Oncology Limited (“Race”) held the 2022 AGM on 24 November in Sydney.  Member's of Race’s Board were present along with CEO, Mr Phil Lynch and CSO, Dr Daniel Tillett, who both  provided a Company update. The meeting and presentation were followed by an interactive Q+A.

We understand that some of our shareholders were not able to make the in-person AGM, so we recorded the session to ensure all shareholders can access a copy of the meeting.

Please view the video and ask us any questions you might have! Our team will endeavour to get back to all questions soon.